Finally, the authors of relevant publications and listed pharmaceutical companies were contacted in order to identify additional published and non-published trials.
Finalmente, se contactó a los autores de las publicaciones relevantes y a compañías farmacéuticas relacionadas con el fin de identificar estudios adicionales publicados y no publicados.